DRONE VOLT, a manufacturer of professional civilian drones and an expert in embedded solutions, announces the success of new missions to detect mines and explosive remnants carried out using its ...
CHICAGO, IL / ACCESS Newswire / October 21, 2025 / Honeycomb Insurance, a deep-tech digital MGA specializing in tailored property and casualty coverage for residential landlords and condominium associ ...
Revenuesfor the first nine months of 2025 were €213 million, compared to €203 million in the same period of 2024, up 5.2 at constant currency and perimeter Gameloft is successfully pursuing ...
Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025 ...
Continued Acceleration in Like-for-like Growth1 Progress across All Divisions Sales: 32.80 billion euros, +3.4% like-for-like2 (+3.7% adjusted1), +1.2% reported.Growth in all Divisions.
B.C. Ltd. ("131" or the "Company") and Marviken Ontario Inc. ("Marviken") are pleased to announce that the Company, Marviken ...
West Coast Community Bancorp ("Bancorp,"OTCQX: WCCB), the parent company of West Coast Community Bank (the "Bank") ...
During the first nine months of the year, SEK experienced strong growth in business volumes. New credit and guarantee agreements totaling Skr 97.3 billion were signed, of which Skr 40.3 billion were s ...
Greene County Bancorp, Inc. (the "Company") (NASDAQ: GCBC), the holding company for the Bank of Greene County and its subsidiary Greene County Commercial ...
Genmab A/S: Genmab Commences Tender Offer for All Issued and Outstanding Common Shares of Merus N.V.
Media ReleaseCOPENHAGEN, Denmark; October 21, 2025 Genmab A/S (Nasdaq: GMAB) ("Genmab") announced today that it is commencing, through a wholly owned subsidiary, Genmab Holding II B.V. ("Purchaser") ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives ...
Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the US Orphan Drug Designation previously granted by the European Medicines Agency in May 2025 ASHBURN, Va., Oct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results